Clinical Trial Update: n-3 PUFAs, Irisin and Maternal Glucose Metabolism From Pregnancy to Postpartum

View source ↗

Summary

This ClinicalTrials.gov entry reports a completed study evaluating the effects of omega-3 fatty acids (n-3 PUFAs) and irisin on maternal glucose metabolism from…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Diseases
• Emotional and Behavioral Disorders in Children
• Gestational Diabetes Mellitus
• Neurodevelopmental Disorders
• Postpartum Diabetes Mellitus

Drugs mentioned

• Irisin (irisin)
• Omega-3 fatty acids (n-3 PUFAs) (omega-3 polyunsaturated fatty acids)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Gestational Diabetes Mellitus, Neurodevelopmental Disorders | Status: COMPLETED